• Opus Genetics, Ocuphire Merger to Boost Advancement of Several IRD Gene Therapies

  • Oct 23 2024
  • Length: 3 mins
  • Podcast

Opus Genetics, Ocuphire Merger to Boost Advancement of Several IRD Gene Therapies

  • Summary

  • Merger will provide additional capital for gene therapy development.
    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Opus Genetics, Ocuphire Merger to Boost Advancement of Several IRD Gene Therapies

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.